Editor-in-Chief’s Commentary: Innovation in Publications Stephen P. Spielberg Commentary 30 December 2013 Pages: 151 - 151
Cycle Time Metrics for Multisite Clinical Trials in the United States Diana AbbottRobert CaliffSwati Chakraborty Clinical Trials Open access 30 December 2013 Pages: 152 - 160
Quality by Design in Clinical Trials: A Collaborative Pilot With FDA Kenneth SprengerDavid NickersonBriggs W. Morrison Clinical Trials 30 December 2013 Pages: 161 - 166
Evaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials: A Meta-analysis Jenny J. ZhangHuanyu ChenRajeshwari Sridhara Clinical Trials 30 December 2013 Pages: 167 - 174
Life Cycle Modeling and Simulation: Current Practice and Future Impact on Health Care Innovation and Delivery Michael O’KellySeth BerryAndrew Garrett Clinical Trials 30 December 2013 Pages: 175 - 182
Expanding Consumer Medication Access: The Time Is Now Sally A. HustonSuzan KucukarslanSujit S. Sansgiry Drug Information 30 December 2013 Pages: 183 - 189
Medical Information Specialists: Benchmarks in Practice Kimberly WuLaura Smith SchmelzSara M. Doshi Drug Information 30 December 2013 Pages: 190 - 197
Drug Information Activity and Nonprescription Requests Over the Malaysian Counter Tahir Mehmood KhanPromise EmekaAmer Hayat Khan Drug Information 30 December 2013 Pages: 198 - 202
Health Care Professionals’ Expectations of the Medical Science Liaison: A Blinded Survey Robert J. MossJimmy Black Drug Information 30 December 2013 Pages: 203 - 208
Medical Information Contact Centers: Challenges and Best Practices David BowersTimothy Fish Drug Information 30 December 2013 Pages: 209 - 213
Changes to Prescription Drug Pediatric Labeling: Awareness by Practicing Pediatricians Irwin G. MartinSiva Rama Krishna ThottempudiDaniel A. C. Frattarelli Special Populations 30 December 2013 Pages: 214 - 218
Drug Information: Prescribers’ Need for and Access to Drug Information Resources in Ethiopia Nezif HussienSeid MusaSultan Suleman Global Perspectives 30 December 2013 Pages: 219 - 225
The Effect of Market-Based Economic Factors on the Adoption of Orphan Drugs Across Multiple Countries John T. MatthewsLucas Glass Global Perspectives 30 December 2013 Pages: 226 - 234
A Practical Estimation Method for Analyzing Adverse Drug Reactions Using Data Mining Yuko ShirakuniKousuke OkamotoTatsuya Takagi Statistics 30 December 2013 Pages: 235 - 241
Sample Size Calculation for Bioequivalence Studies Assessing Drug Effect and Food Effect at the Same Time With a 3-Treatment Williams Design Jiacheng YuanTiejun TongMan-Lai Tang Statistics 30 December 2013 Pages: 242 - 247
Safety Information From Spontaneous and Literature Adverse Reaction Reports: A Comparison Janine KloseSimone FröhlingAxel Nolting Drug Safety 30 December 2013 Pages: 248 - 255
Validation of QT Interval Correction Methods When a Drug Changes Heart Rate Qianyu DangJoanne Zhang Drug Safety 30 December 2013 Pages: 256 - 260
Factors Related to Regulatory Approval of Late-Stage Development Compounds: Analysis of Japanese Pharmaceutical Company Activities, 1995–2007 Atsushi TsukamotoMasayuki KanekoMamoru Narukawa Regulatory Science 30 December 2013 Pages: 261 - 267
A Review of Regulatory Mechanisms Used by the WHO, EU, and US to Facilitate Access to Quality Medicinal Products in Developing Countries With Constrained Regulatory Capacities Yauba SaiduDario De AngelisAnne Marie Georges Regulatory Science 30 December 2013 Pages: 268 - 276